Cognition Therapeutics, Inc. Common Stock
CGTX Real Time Price USDRecent trades of CGTX by members of U.S. Congress
|
Name
|
Type
|
Shares
|
Price
|
Shares Held
|
Date
|
Reported
|
|---|
|
Investor
|
Shares
|
Change in Shares
|
Market Value
|
Date
|
Reported
|
|---|
|
Investor
|
Type
|
Shares
|
Change in Shares
|
Market Value
|
Date
|
Reported
|
|---|
Recently reported changes by institutional investors
Quarterly net insider trading by CGTX's directors and management
Government lobbying spending instances
Estimated quarterly lobbying spending
CGTX Revenue by Segment or Geography
No Revenue by Segment data for this ticker
No Revenue by Geography data for this ticker
New patents grants
-
Patent Title: Compositions for treating neurodegenerative diseases May. 14, 2024
-
Patent Title: Isoindoline compositions and methods for treating neurodegenerative disease Jul. 04, 2023
-
Patent Title: Compositions for treating neurodegenerative diseases Jan. 04, 2022
-
Patent Title: Isoindoline compositions and methods for treating neurodegenerative disease Feb. 19, 2019
-
Patent Title: Inhibitors of cognitive decline Nov. 14, 2017
-
Patent Title: Isoindoline compositions and methods for treating neurodegenerative disease Oct. 24, 2017
-
Patent Title: Isolated compounds from turmeric oil and methods of use Nov. 22, 2016
-
Patent Title: Inhibitors of cognitive decline Jun. 14, 2016
-
Patent Title: Inhibitors of cognitive decline Nov. 24, 2015
-
Patent Title: Inhibitors of cognitive decline Jul. 01, 2014
-
Patent Title: Inhibitors of cognitive decline May. 25, 2010
Federal grants, loans, and purchases
Estimated quarterly amount awarded from public contracts
Recent insights relating to CGTX
Number of mentions of CGTX in WallStreetBets Daily Discussion
Recent picks made for CGTX stock on CNBC
ETFs with the largest estimated holdings in CGTX
|
Shareholder
|
Shares Held
|
|---|
* These are estimates based on data taken from SEC filings. There may be inaccuracies due to parsing errors, accidental double-counting, incorrect classification of indirectly owned shares, or any other number of issues.
The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.
The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.Sign Up to view CGTX Smart Score
See concise summaries of analyst reports, presenting both bullish and bearish arguments for a stock.
Example:
The Bulls Say summary highlights positive aspects of the stock.
The Bears Say summary points out potential risks and negative aspects of the stock.